Ruxolitinib is an effective steroid sparing agent in children with steroid refractory/dependent bronchiolitis obliterans syndrome after allogenic hematopoietic cell transplantation

Saved in:
Bibliographic Details
Published in:Bone marrow transplantation (Basingstoke) 2019-07, Vol.54 (7), p.1158-1160
Main Authors: Schoettler, Michelle, Duncan, Christine, Lehmann, Leslie, Furutani, Elissa, Subramaniam, Meera, Margossian, Steven
Format: Article
Language:English
Subjects:
692/308/2171
692/699/249/1529
Adolescent
Adult
Allografts
Bronchiolitis
Bronchiolitis obliterans
Bronchiolitis Obliterans - drug therapy
Bronchiolitis Obliterans - etiology
Bronchopneumonia
Care and treatment
Cell Biology
Child
Chronic Disease
Correspondence
Drug therapy
Female
Graft vs Host Disease - drug therapy
Graft vs Host Disease - etiology
Hematology
Hematopoietic Stem Cell Transplantation
Humans
Internal Medicine
Male
Medicine
Medicine & Public Health
Public Health
Pyrazoles - administration & dosage
Pyrazoles - adverse effects
Retrospective Studies
Stem Cells
Steroids
Transplantation
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0268-3369
1476-5365
DOI:10.1038/s41409-019-0450-3